PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORS.
about
PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORS.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@en
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@nl
type
label
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@en
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@nl
prefLabel
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@en
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@nl
P2093
P2860
P1476
PRE-CLINICAL AND CLINICAL VALI ...... Y, LOW GROWTH FRACTION TUMORS.
@en
P2093
Eric J Sorscher
Jeong S Hong
William B Parker
P2860
P577
2016-01-01T00:00:00Z